Acute and Selective Regulation of Glyceroneogenesis and Cytosolic Phosphoenolpyruvate Carboxykinase in Adipose Tissue by Thiazolidinediones in Type 2 Diabetes

Overview

Journal Diabetologia

Specialty Endocrinology

Date 2007 Jan 24

PMID 17242918

Citations 22

Authors

T Cadoudal

J M Blouin

M Collinet

F Fouque

G D Tan

E Loizon

E G Beale

K N Frayn

F Karpe

H Vidal

C Benelli

C Forest

Affiliations

Soon will be listed here.

Abstract

Aims/hypothesis: Regulation of glyceroneogenesis and its key enzyme cytosolic phosphoenolpyruvate carboxykinase (PEPCK-C) plays a major role in the control of fatty acid release from adipose tissue. Here we investigate the effect of rosiglitazone on the expression of genes involved in fatty acid metabolism and the resulting metabolic consequences.

Materials And Methods: Rosiglitazone was administered to Zucker fa/fa rats for 4 days and to 24 diabetic patients for 12 weeks, then mRNA expression for the genes encoding PEPCK-C, mitochondrial PEPCK, adipocyte lipid-binding protein, glycerol kinase, lipoprotein lipase and glycerol-3-phosphate dehydrogenase was examined in s.c. adipose tissue by real-time RT-PCR. Glyceroneogenesis was determined using [1-(14)C]pyruvate incorporation into lipids. Cultured adipose tissue explants from overweight women undergoing plastic surgery were incubated with rosiglitazone for various times before mRNA determination and analysis of PEPCK-C protein, activity and glyceroneogenesis.

Results: Rosiglitazone administration to rats induced the expression of the gene encoding PEPCK-C mRNA (PCK1) and PEPCK-C activity in adipose tissue with a resulting 2.5-fold increase in glyceroneogenesis. This was accompanied by an improvement in dyslipidaemia as demonstrated by the decrease in plasma NEFAs and triacylglycerol. In rosiglitazone-treated diabetic patients, PCK1 mRNA was raised 2.5-fold in s.c. adipose tissue. Rosiglitazone treatment of adipose tissue explants from overweight women caused a selective augmentation in PCK1 mRNA which reached a maximum of 9-fold at 14 h, while mRNA for other genes remained unaffected. Experiments with inhibitors showed a direct and transcription-only effect, which was followed by an increase in PEPCK-C protein, enzyme activity and glyceroneogenesis.

Conclusions/interpretation: These results favour adipocyte glyceroneogenesis as the initial thiazolidinedione-responsive pathway leading to improvement in dyslipidaemia.

Citing Articles

Naringenin and β-carotene convert human white adipocytes to a beige phenotype and elevate hormone- stimulated lipolysis.

Coulter A, Greenway F, Zhang D, Ghosh S, Coulter C, James S Front Endocrinol (Lausanne). 2023; 14():1148954.

PMID: 37143734 PMC: 10153092. DOI: 10.3389/fendo.2023.1148954.

Hypoxia as a Double-Edged Sword to Combat Obesity and Comorbidities.

Wang R, Sun Q, Wu X, Zhang Y, Xing X, Lin K Cells. 2022; 11(23).

PMID: 36496995 PMC: 9736735. DOI: 10.3390/cells11233735.

The long noncoding RNA ADIPINT regulates human adipocyte metabolism via pyruvate carboxylase.

Kerr A, Wang Z, Wang N, Kwok K, Jalkanen J, Ludzki A Nat Commun. 2022; 13(1):2958.

PMID: 35618718 PMC: 9135762. DOI: 10.1038/s41467-022-30620-0.

Induction of Metabolic Zonation in Primary Hepatocytes Requires Both Near-Physiological Oxygen Concentration and Flux.

Scheidecker B, Shinohara M, Sugimoto M, Danoy M, Nishikawa M, Sakai Y Front Bioeng Biotechnol. 2020; 8:524.

PMID: 32656187 PMC: 7325921. DOI: 10.3389/fbioe.2020.00524.

Anti-Diabetogenic Properties of Mineralocorticoid Receptor Antagonists: Implications for Enhanced Safety and Efficacy of Post-Transplantation Pharmacotherapies.

Ming Y, Stefano G, Kream R, Zhuang Q Med Sci Monit. 2019; 25:1102-1104.

PMID: 30739121 PMC: 6378856. DOI: 10.12659/MSM.914340.

References

Chen J, Peacock E, Samady W, Turner S, Neese R, Hellerstein M . Physiologic and pharmacologic factors influencing glyceroneogenic contribution to triacylglyceride glycerol measured by mass isotopomer distribution analysis. J Biol Chem. 2005; 280(27):25396-402. DOI: 10.1074/jbc.M413948200. View

Duplus E, Benelli C, Reis A, Fouque F, Velho G, Forest C . Expression of phosphoenolpyruvate carboxykinase gene in human adipose tissue: induction by rosiglitazone and genetic analyses of the adipocyte-specific region of the promoter in type 2 diabetes. Biochimie. 2004; 85(12):1257-64. DOI: 10.1016/j.biochi.2003.10.016. View

Brito S, Festuccia W, Kawashita N, Moura M, Xavier A, Garofalo M . Increased glyceroneogenesis in adipose tissue from rats adapted to a high-protein, carbohydrate-free diet: role of dietary fatty acids. Metabolism. 2005; 55(1):84-9. DOI: 10.1016/j.metabol.2005.07.010. View

Ballard F, Hanson R, Leveille G . Phosphoenolpyruvate carboxykinase and the synthesis of glyceride-glycerol from pyruvate in adipose tissue. J Biol Chem. 1967; 242(11):2746-50. View

Mayerson A, Hundal R, Dufour S, Lebon V, Befroy D, Cline G . The effects of rosiglitazone on insulin sensitivity, lipolysis, and hepatic and skeletal muscle triglyceride content in patients with type 2 diabetes. Diabetes. 2002; 51(3):797-802. PMC: 2995527. DOI: 10.2337/diabetes.51.3.797. View

Reshef L, Hanson R, Ballard F . Glyceride-glycerol synthesis from pyruvate. Adaptive changes in phosphoenolpyruvate carboxykinase and pyruvate carboxylase in adipose tissue and liver. J Biol Chem. 1969; 244(8):1994-2001. View

Tan G, Fielding B, Currie J, Humphreys S, Desage M, Frayn K . The effects of rosiglitazone on fatty acid and triglyceride metabolism in type 2 diabetes. Diabetologia. 2004; 48(1):83-95. DOI: 10.1007/s00125-004-1619-9. View

van Harmelen V, Reynisdottir S, Cianflone K, Degerman E, Hoffstedt J, Nilsell K . Mechanisms involved in the regulation of free fatty acid release from isolated human fat cells by acylation-stimulating protein and insulin. J Biol Chem. 1999; 274(26):18243-51. DOI: 10.1074/jbc.274.26.18243. View

Chaput E, Saladin R, Silvestre M, Edgar A . Fenofibrate and rosiglitazone lower serum triglycerides with opposing effects on body weight. Biochem Biophys Res Commun. 2000; 271(2):445-50. DOI: 10.1006/bbrc.2000.2647. View

10.

Riserus U, Tan G, Fielding B, Neville M, Currie J, Savage D . Rosiglitazone increases indexes of stearoyl-CoA desaturase activity in humans: link to insulin sensitization and the role of dominant-negative mutation in peroxisome proliferator-activated receptor-gamma. Diabetes. 2005; 54(5):1379-84. DOI: 10.2337/diabetes.54.5.1379. View

11.

Tan G, Debard C, Tiraby C, Humphreys S, Frayn K, Langin D . A "futile cycle" induced by thiazolidinediones in human adipose tissue?. Nat Med. 2003; 9(7):811-2; author reply 812. DOI: 10.1038/nm0703-811. View

12.

Okuno A, Tamemoto H, Tobe K, Ueki K, Mori Y, Iwamoto K . Troglitazone increases the number of small adipocytes without the change of white adipose tissue mass in obese Zucker rats. J Clin Invest. 1998; 101(6):1354-61. PMC: 508690. DOI: 10.1172/JCI1235. View

13.

Glorian M, Duplus E, Beale E, Scott D, GRANNER D, Forest C . A single element in the phosphoenolpyruvate carboxykinase gene mediates thiazolidinedione action specifically in adipocytes. Biochimie. 2001; 83(10):933-43. DOI: 10.1016/s0300-9084(01)01343-8. View

14.

Guan H, Li Y, Jensen M, Newgard C, Steppan C, Lazar M . A futile metabolic cycle activated in adipocytes by antidiabetic agents. Nat Med. 2002; 8(10):1122-8. DOI: 10.1038/nm780. View

15.

Tordjman J, Chauvet G, Quette J, Beale E, Forest C, Antoine B . Thiazolidinediones block fatty acid release by inducing glyceroneogenesis in fat cells. J Biol Chem. 2003; 278(21):18785-90. DOI: 10.1074/jbc.M206999200. View

16.

Bogacka I, Xie H, Bray G, Smith S . The effect of pioglitazone on peroxisome proliferator-activated receptor-gamma target genes related to lipid storage in vivo. Diabetes Care. 2004; 27(7):1660-7. DOI: 10.2337/diacare.27.7.1660. View

17.

Guan H, Ishizuka T, Chui P, Lehrke M, Lazar M . Corepressors selectively control the transcriptional activity of PPARgamma in adipocytes. Genes Dev. 2005; 19(4):453-61. PMC: 548946. DOI: 10.1101/gad.1263305. View

18.

Tan G, Debard C, Funahashi T, Humphreys S, Matsuzawa Y, Frayn K . Changes in adiponectin receptor expression in muscle and adipose tissue of type 2 diabetic patients during rosiglitazone therapy. Diabetologia. 2005; 48(8):1585-9. DOI: 10.1007/s00125-005-1835-y. View

19.

Vaughan M . The production and release of glycerol by adipose tissue incubated in vitro. J Biol Chem. 1962; 237:3354-8. View

20.

Hallakou S, Doare L, Foufelle F, Kergoat M, Guerre-Millo M, Berthault M . Pioglitazone induces in vivo adipocyte differentiation in the obese Zucker fa/fa rat. Diabetes. 1997; 46(9):1393-9. DOI: 10.2337/diab.46.9.1393. View